A combination of the personalized cancer vaccine intismeran autogene and Merck's Keytruda just barely cleared analysts’ ...
InvestorsHub on MSN
Moderna stock plunges as apparent leak reveals phase 3 melanoma vaccine data
Key Takeaways ・Moderna Inc. (NASDAQ:MRNA) sank as much as roughly 25% intraday after apparent Phase 3 results for its personalized melanoma vaccine surfaced online ahead of an embargoed ...
For Trade and Medical Media Only Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO ® (rezafungin acetate) for prophylaxis of invasive f ...
Iovance Biotherapeutics, a Philadelphia-based commercial biotechnology company developing tumor infiltrating lymphocyte (TIL) ...
Fenebrutinib FENtrepid and FENhance 1 & 2 late-breaking data demonstrate a therapeutic effect on chronic active lesions, ...
Cerenome, Inc. announced that new preclinical data presented at the 16th Biennial Rivkin Ovarian Cancer Research Symposium illustrate the emerging immunomodulatory properties of REYOBIQ? , its ...
A national survey of 1,763 U.S. adults found that specified perceptions of science statistically accounted for partisan gaps ...
Hematoma growth: In an exploratory adjusted analysis, at 72 hours, normalized hematoma volume remained essentially stable with BIOX-101 (-1.9% from baseline), compared with a 25.5% increase with ...
According to a recent presentation by district leaders, who described those numbers as “steady progress” and a small ...
While Longmeadow students outperformed their peers in the state on the MCAS, stagnant and declining scores have school ...
How Americans view science and scientists is strongly associated with whether they think vaccines are safe and effective - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results